Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 4/2007

Content (15 Articles)

Review

Vaccination therapy in prostate cancer

Andrea Marrari, Manuela Iero, Lorenzo Pilla, Sergio Villa, Roberto Salvioni, Riccardo Valdagni, Giorgio Parmiani, Licia Rivoltini

Original Article

huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models

Kin-Ming Lo, Yan Lan, Scott Lauder, Jinyang Zhang, Beatrice Brunkhorst, Guozhong Qin, Rakesh Verma, Nigel Courtenay-Luck, Stephen D. Gillies

Original Article

Exchanging human Fcγ1 with murine Fcγ2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model

Petra Lutterbuese, Klaus Brischwein, Robert Hofmeister, Sandrine Crommer, Grit Lorenczewski, Laetitia Petersen, Sandra Lippold, Antonio da Silva, Mathias Locher, Patrick A. Baeuerle, Bernd Schlereth

Original Article

Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study

Hirohito Kobayashi, Yoshimasa Tanaka, Junji Yagi, Yukinari Osaka, Hayakazu Nakazawa, Takehiko Uchiyama, Nagahiro Minato, Hiroshi Toma

Original Article

Guided selection of an anti-gamma-seminoprotein human Fab for antibody directed enzyme prodrug therapy of prostate cancer

Qing Zhang, Si-He Zhang, Ming-Quan Su, Guo-Qiang Bao, Jia-Yun Liu, Jing Yi, Jian-Jun Shen, Xiao-Ke Hao

Original Article

Regulation of galectin-1 expression by transforming growth factor β1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape

Cecilia M. Daroqui, Juan M. Ilarregui, Natalia Rubinstein, Mariana Salatino, Marta A. Toscano, Paula Vazquez, Andrei Bakin, Lydia Puricelli, Elisa Bal de Kier Joffé, Gabriel A. Rabinovich

Original Article

Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fludarabine/genistein

Amal Mansour, Victor T. Chang, Shanti Srinivas, Jonathan Harrison, Elizabeth Raveche

Original Article

Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients

Houssem Benlalam, Virginie Vignard, Amir Khammari, Annabelle Bonnin, Yann Godet, Marie-Christine Pandolfino, Francine Jotereau, Brigitte Dreno, Nathalie Labarrière

Original Article

Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patient

Rikke Bæk Sørensen, Sine Reker Hadrup, Tania Køllgaard, Inge Marie Svane, Per thor Straten, Mads Hald Andersen

Original Article

R-Ras promotes metastasis of cervical cancer epithelial cells

Nancy Mora, Ricardo Rosales, Carlos Rosales

Original Article

Synthesis of glycosylated human tumor necrosis factor α coupled with N-acetylneuraminic acid

Akiko Hayashi, Taku Chiba, Hidetoshi Hayashi, Satoshi Sasayama, Toshiyuki Ishiguro, Kikuo Onozaki

Original Article

N-acetylneuraminic acid coupled human recombinant TNFα exhibits enhanced anti-tumor activity against Meth-A fibrosarcoma and reduced toxicity

Akiko Hayashi, Hidetoshi Hayashi, Taku Chiba, Satoshi Sasayama, Kikuo Onozaki

Original Article

CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver

Tony Kenna, Margaret O’Brien, Andrew E. Hogan, Mark A. Exley, Steven A. Porcelli, John E. Hegarty, Cliona O’Farrelly, Derek G. Doherty

Short Communication

Decreased response rates by the combination of histamine and IL-2 in melphalan-based isolated limb perfusion

Flavia Brunstein, Saske Hoving, Gisela aan de Wiel-Ambagtsheer, Ernst A. de Bruijn, Gunther Guetens, Alexander M. M. Eggermont, Timo L. M. ten Hagen

Meeting Report

International Meeting “Immunotherapy of Cancer: Challenges and Needs”

Maria Ferrantini, Imerio Capone, Francesco M. Marincola, Giorgio Parmiani, Filippo Belardelli

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine